C. Dudkowski

The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus

Zhen Zhao, E. Schmidt, C. Dudkowski, 2016, European Journal of Clinical Pharmacology.

Single-Center Evaluation of the Single-Dose Pharmacokinetics of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Renal Impairment

R. Preston, D. Sica, O. Lenz, 2013, Clinical Pharmacokinetics.

Single‐Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment

R. Preston, A. Karim, A. Alonso, 2017, Journal of clinical pharmacology.

Effects of Age, Sex, and Race on the Safety and Pharmacokinetics of Single and Multiple Doses of Azilsartan Medoxomil in Healthy Subjects

Robert Harrell, A. Karim, Wencan Zhang, 2015, Clinical Pharmacokinetics.

Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults

T. Wells, Zhen Zhao, A. Juhasz, 2016, European Journal of Clinical Pharmacology.

Characterization of metabolites of Celecoxib in rabbits by liquid chromatography/tandem mass spectrometry.

J. Yuan, D. Yang, Y. Wang, 2000, Journal of mass spectrometry : JMS.

Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey

J. Yuan, D. Yang, S. Paulson, 2000, Xenobiotica; the fate of foreign compounds in biological systems.

Effects of Food Intake on the Pharmacokinetics of Azilsartan Medoxomil and Chlorthalidone Alone and in Fixed‐Dose Combination in Healthy Adults

A. Karim, M. Munsaka, C. Dudkowski, 2016, Clinical pharmacology in drug development.